Adial Pharmaceuticals (ADIL) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.5
-0.39
-0.29
-0.18

Details

Expected EPS
-0.22
Actual EPS
-0.18
Surprise EPS
0.04
Surprise Percent
+18.18%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -0.18 per share for Q3 2025.

0 Comments

Share your thoughts